Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

類似資料

• Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
  著者:: Rugo, H. S., 等
  出版事項: (2014)
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
  著者:: Gnant, Michael, 等
  出版事項: (2013)
• Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2
  著者:: Kathleen I. Pritchard, 等
  出版事項: (2013)
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
  著者:: Michael Gnant, 等
  出版事項: (2013)
• Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial
  著者:: Howard A. Burris, 等
  出版事項: (2013)